Generic Cytoxan products are currently manufactured by Roxane Laboratories and Baxter Healthcare Corp. Generic Cytoxan tablets are available in two strengths, and the injectable version comes in various vial sizes. The FDA has given every generic version of Cytoxan an "AB" or "AP" rating, which means that these products should be equivalent to brand-name Cytoxan.
Cytoxan® (cyclophosphamide) is a prescription medication used to treat various types of cancer, such as breast cancer, leukemia, and ovarian cancer. It is also used to treat a kidney disorder called nephrotic syndrome in children. It is part of a group of chemotherapy medications called alkylating agents.
Cytoxan is made by Bristol-Myers Squibb. However, it has since come off patent and is available as a generic.
Generic Cytoxan tablets are available in the following strengths:
- Cyclophosphamide 25 mg
- Cyclophosphamide 50 mg.
Generic injectable Cytoxan is available in various vial sizes.
Generic Cytoxan is made by the following companies:
- Baxter Healthcare Corp.
- Roxane Laboratories.
All generic medications must have certain tests to compare them to brand-name medications. The U.S. Food and Drug Administration (FDA) then looks at these tests to decide if the generics are equivalent to the brand-name medications and assigns each generic a rating. An "AB" or "AP" rating means that the FDA has determined that a generic medication is equivalent to its brand-name version. All of these generic Cytoxan versions currently available have an "AB" or "AP" rating, meaning they should be equivalent to Cytoxan.
However, generic medications are allowed to have different inactive ingredients than their brand-name equivalents. These inactive ingredients might include fillers, dyes, or other ingredients that may cause problems for people with allergies or sensitivities.